CN105477039A - 一种水飞蓟素plga纳米粒及其制备方法 - Google Patents
一种水飞蓟素plga纳米粒及其制备方法 Download PDFInfo
- Publication number
- CN105477039A CN105477039A CN201610005607.8A CN201610005607A CN105477039A CN 105477039 A CN105477039 A CN 105477039A CN 201610005607 A CN201610005607 A CN 201610005607A CN 105477039 A CN105477039 A CN 105477039A
- Authority
- CN
- China
- Prior art keywords
- silymarin
- plga
- preparation
- mixed solution
- acetone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610005607.8A CN105477039A (zh) | 2016-01-04 | 2016-01-04 | 一种水飞蓟素plga纳米粒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610005607.8A CN105477039A (zh) | 2016-01-04 | 2016-01-04 | 一种水飞蓟素plga纳米粒及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105477039A true CN105477039A (zh) | 2016-04-13 |
Family
ID=55664554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610005607.8A Pending CN105477039A (zh) | 2016-01-04 | 2016-01-04 | 一种水飞蓟素plga纳米粒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105477039A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110897908A (zh) * | 2019-12-16 | 2020-03-24 | 重庆医药高等专科学校 | 水飞蓟素纳米抗皱眼霜及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614239A (zh) * | 2012-04-25 | 2012-08-01 | 晨光生物科技集团天津有限公司 | 一种水飞蓟素复合物纳米粒及制备方法 |
-
2016
- 2016-01-04 CN CN201610005607.8A patent/CN105477039A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614239A (zh) * | 2012-04-25 | 2012-08-01 | 晨光生物科技集团天津有限公司 | 一种水飞蓟素复合物纳米粒及制备方法 |
Non-Patent Citations (3)
Title |
---|
梅兴国主编: "《微载体药物递送系统》", 30 November 2009, 华中科技大学出版社 * |
罗杰英等: "《现代物理药剂学理论与实践》", 30 April 2005, 上海科学技术文献 * |
韦超等主编: "《药剂学(第2版)》", 31 August 2012, 河南科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110897908A (zh) * | 2019-12-16 | 2020-03-24 | 重庆医药高等专科学校 | 水飞蓟素纳米抗皱眼霜及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705469B (zh) | 一种和厚朴酚纳米粒及其制备方法 | |
CN101361713B (zh) | 姜黄素纳米结晶制剂的制备方法 | |
CN101982168B (zh) | 一种槲皮素纳米胶束制剂及其制备方法 | |
CN102824356A (zh) | 一种黄芩苷纳晶混悬剂、纳晶干粉及其制备方法 | |
Casamonti et al. | Andrographolide loaded in micro-and nano-formulations: improved bioavailability, target-tissue distribution, and efficacy of the “king of bitters” | |
CN101829061A (zh) | 一种紫杉醇纳米颗粒组合物及其制备方法 | |
CN103211759A (zh) | 葛根素纳米晶药用组合物及其制备方法 | |
CN102008439A (zh) | 一种姜黄素包覆脂质体制剂及其制备方法 | |
WO2008052410A1 (fr) | Composition à base de supermolécules de coenzyme hydrosoluble q10 et son procédé de préparation | |
CN102078312A (zh) | 一种姜黄素类化合物干粉吸入剂及其制备方法和用途 | |
CN102228430A (zh) | 水飞蓟宾磷脂复合物的纳米混悬剂及其制备方法 | |
CN103054807A (zh) | 一种肌内或皮下注射用姜黄素微粉组合物及其制备方法和用途 | |
CN102357075A (zh) | 一种多西他赛纳米制剂及其制备方法 | |
CN102058566A (zh) | 一种冬凌草甲素类成分干粉吸入剂及其制备方法和用途 | |
Huang et al. | Advantages of nanotechnology-based Chinese herb drugs on biological activities | |
CN102688200A (zh) | 植物类抗癌靶向纳米制剂及其制备方法 | |
CN101088523B (zh) | 黄芩天然活性成分的固体脂质纳米粒及其制备方法和制剂 | |
CN104274401A (zh) | 一种基于hcpt-peg的喜树碱类药物的高载药纳米混悬剂及其制备方法 | |
JP2020121974A (ja) | 天然材料の粒子および抽出物を含むナノ懸濁液 | |
CN102961368A (zh) | 一种姜黄素纳米混悬剂及其制备方法 | |
CN105477039A (zh) | 一种水飞蓟素plga纳米粒及其制备方法 | |
CN102579737B (zh) | 一种血竭纳米药物结晶制剂及其制备方法 | |
CN103637984A (zh) | 一种黄芩苷纳米结晶及其制备方法 | |
CN103070825A (zh) | 一种肌内或皮下注射用姜黄素微粒混悬液及其制备方法和用途 | |
CN101310717A (zh) | 丹参酮iia聚乳酸纳米粒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: He Jing Inventor after: Zhu Zhaojing Inventor after: Yang Yanyin Inventor after: Qiu Yanchuan Inventor after: Lin Fengyun Inventor after: Jiang Shangfei Inventor after: Cai Qin Inventor after: Zhong Ling Inventor after: Xing Yuzheng Inventor before: He Jing Inventor before: Zhu Zhaojing Inventor before: Yang Yanyin Inventor before: Qiu Yanchuan Inventor before: Lin Fengyun Inventor before: Jiang Shangfei Inventor before: Cai Qin Inventor before: Zhong Ling Inventor before: Xing Yuzheng |
|
COR | Change of bibliographic data | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160413 |